发明名称 BICYCLIC COMPOUND AND PHARMACEUTICAL USE THEREOF
摘要 <p>Disclosed is a compound represented by the following formula: (wherein R<SUP>1</SUP> presents an optionally substituted hydrocarbon group, an optionally substituted amino group, an optionally substituted hydroxy group or an optionally substituted heterocyclic group; R<SUP>2</SUP> represents a hydrogen atom or an optionally substituted hydrocarbon group; Xa and Xb each represents C, N, O or S; Xc and Xd each represents C or N; m represents a number of 0-2; n represents a number of 1-3; ring A represents an optionally substituted 5-membered ring; ring B represents an optionally substituted 6-membered ring; and ring C represents an optionally substituted 3- to 5-membered ring; provided that when Xa, Xc and Xd are C, Xb is N or S) or a salt thereof, which is useful as an agent for prevention/treatment of diseases associated with action of melatonin.</p>
申请公布号 WO2008136382(A1) 申请公布日期 2008.11.13
申请号 WO2008JP58020 申请日期 2008.04.25
申请人 TAKEDA PHARMACEUTICAL COMPANY LIMITED;KOIKE, TATSUKI;TAKAI, TAKAFUMI;HOASHI, YASUTAKA 发明人 KOIKE, TATSUKI;TAKAI, TAKAFUMI;HOASHI, YASUTAKA
分类号 C07D231/56;A61K31/416;A61K31/428;A61K31/433;A61K31/437;A61P1/04;A61P3/06;A61P3/10;A61P5/00;A61P7/10;A61P7/12;A61P9/00;A61P9/10;A61P9/12;A61P11/08;A61P15/00;A61P15/08;A61P19/10;A61P25/14;A61P25/16;A61P25/18;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P27/02;A61P27/06;A61P35/00;A61P35/02;A61P37/00;A61P43/00;C07D275/04;C07D277/64;C07D285/14;C07D471/04;C12N15/00 主分类号 C07D231/56
代理机构 代理人
主权项
地址